For research use only. Not for therapeutic Use.
NSC-207895(Cat No.:I002367) has been shown to inhibit the MDMX protein with an IC50 of 2.5 μM. This inhibition promotes p53 stabilization/activation and DNA damage while also regulating the MDM2 E3 ligase. NSC-207895’s ability to modulate these key proteins involved in cancer cell survival and proliferation suggests its potential as an anti-cancer agent. However, further studies are required to determine its effectiveness and safety for clinical use.
Catalog Number | I002367 |
CAS Number | 58131-57-0 |
Synonyms | 4-(4-methylpiperazin-1-yl)-7-nitro-3-oxido-2,1,3-benzoxadiazol-3-ium |
Molecular Formula | C11H13N5O4 |
Purity | ≥95% |
Target | MDM-2/p53 |
Solubility | Limited solubility |
Storage | Store at -20°C |
IUPAC Name | 4-(4-methylpiperazin-1-yl)-7-nitro-3-oxido-2,1,3-benzoxadiazol-3-ium |
InChI | InChI=1S/C11H13N5O4/c1-13-4-6-14(7-5-13)9-3-2-8(15(17)18)10-11(9)16(19)20-12-10/h2-3H,4-7H2,1H3 |
InChIKey | MWFZDJLPWDCQIL-UHFFFAOYSA-N |
SMILES | CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-] |